End-to-End Platform for Modern Evidence Generation
Purpose-built technology for pharmaceutical clinical development. From dynamic EDC & eCRF building through real-time analytics and audit-ready submissions — RWEOne unifies every stage of your RWE and RWD study lifecycle in a single, compliant, AI-accelerated ecosystem.
Core Technologies Powering Every RWEOne Study
Dynamic EDC & eCRF Builder
Deploy studies in minutes, not months. Build, customize, and version Case Report Forms seamlessly. Our architecture supports industry standards including CDISC/CDASH compliance, ensuring your data is structurally sound from the point of entry.
- Drag-and-drop eCRF design
- CDISC/CDASH aligned question libraries
- Conditional logic & branching
- Full version control & rollback
AI-Driven Validation Engines
Intelligent form validations, outlier detection, and automated query generation dramatically reduce manual source-data-verification workload while maintaining the highest data quality standards.
- Real-time anomaly detection
- Auto-generated data queries
- Predictive SDV prioritization
- CDASH compliance pre-checks
Intelligent Analytics & Dashboards
Transform raw RWD inputs into actionable intelligence. Utilize our real-time dashboards and AI-driven data validation rule sets to identify anomalies instantly and ensure continuous data integrity.
- Real-time study health dashboards
- Cohort & subgroup analytics
- Risk-based monitoring surfaces
- Regulatory-ready data exports
Streamlined Investigator Workflows
Eradicate administrative bottlenecks. Accelerate site readiness with fully digital onboarding workflows and secure, compliant electronic signatures for Clinical Trial Agreements (CTAs).
- Digital CTA eSignatures
- Automated KYC & credentialing
- Document version management
- Site performance dashboards
RabbitMQ-Powered Audit Trails
Transparency built into the code. Rely on comprehensive, event-driven audit logs that track every data point and workflow interaction for unwavering trust and regulatory submission readiness.
- Immutable event-driven logs
- Every change timestamped & attributed
- 21 CFR Part 11 compliant
- One-click audit export packages
Global Site Activation Network
Rapid investigator onboarding across 50+ countries with diverse therapeutic area coverage. High-fidelity patient access and representative real-world data capture at global scale.
- 50+ country coverage
- 15+ therapeutic area expertise
- Pre-qualified investigator panels
- Feasibility & site selection services
Why Global Pharma Chooses RWEOne
Expansive Global Site Network
Accelerate investigator onboarding and patient access. Tap into our established global connections across diverse therapeutic areas to capture high-fidelity, representative data.
AI-Powered Trial Acceleration
AI-driven validations automate the heaviest data burdens, reducing the time and cost of moving from Phase 1 to post-market Phase 4.
Uncompromising Compliance & Security
Robust restricted sponsor access, digital CTA signatures, and immutable event tracking keep you audit-ready from day one.
Unified, End-to-End Execution
Eliminate vendor fragmentation. From study design to advanced analytics, manage your entire RWE lifecycle within a single, interconnected ecosystem.
Integrated Technology Stack
Scaling from Evidence to Ecosystems
We solve your immediate trial needs today while building the infrastructure you need for tomorrow. Start with highly targeted, AI-optimized RWE studies to prove efficacy and safety. As your portfolio grows, seamlessly transition those endpoints into a comprehensive Real-World Data (RWD) lake for continuous, automated evidence generation.
Targeted RWE Studies
- Highly targeted, AI-optimized study design
- Rapid site activation and investigator onboarding
- Prove efficacy and safety endpoints efficiently
Initiate focused, hypothesis-driven RWE studies that leverage our AI platform for rapid patient recruitment, endpoint validation, and interim safety readouts.
Explore Phase 1–2 SolutionsExpanded Data Collection
- Broaden site network and patient populations
- Integrate additional real-world data endpoints
- Scale validation with AI-driven quality checks
Scale your evidence base by expanding site networks and integrating complementary RWD sources. AI validation ensures data quality at every step of the growth trajectory.
Explore Phase 3 SolutionsRWD Lake & Continuous Evidence
- Comprehensive Real-World Data lake architecture
- Continuous, automated evidence generation
- Post-market surveillance & lifecycle insights
Operationalize a living, continuously refreshed RWD asset. Automated pipelines transform real-world endpoints into lifecycle evidence for regulatory, commercial, and medical teams.
Explore Phase 4+ SolutionsExperience Across 15+ Therapeutic Areas
Our in-house clinical team and investigator network span every major and specialty therapeutic area — with deep bench strength in oncology, neurology, and rare disease.
Oncology
Solid tumors, hematological malignancies, biomarker-driven studies.
Cardiovascular
CV outcomes, heart failure, hypertension, lipid disorders.
Neurology
Multiple sclerosis, Alzheimer's, Parkinson's, rare neuro disorders.
Immunology
Rheumatoid arthritis, psoriasis, IBD, transplant outcomes.
Rare Disease
Ultra-rare indications, natural history studies, patient-powered data.
Metabolic
Diabetes, obesity, NAFLD/NASH, endocrine disorders.
Ready to Compress Your Trial Timelines?
Schedule a consultation with our team. We walk you through our platform, discuss your therapeutic area and study objectives, and propose a tailored RWE strategy — with zero obligation.